Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Generics
Pharma
Aurobindo must divest 4 drugs to complete Lannett buyout: FTC
Before Aurobindo can complete its $250 million acquisition of Lannet, it will have to divest four drugs, the FTC said.
Kevin Dunleavy
Jun 18, 2026 3:45pm
In a big win for generics drugmakers, SCOTUS sides with Hikma
Jun 4, 2026 3:11pm
Pfizer inks settlements with 2 generic Vyndamax contenders
Apr 27, 2026 11:23am
Sun Pharma snaps up women's health leader Organon for $11.75B
Apr 27, 2026 11:06am
FDA's Makary shares policy requests with Congress
Apr 7, 2026 11:04am
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
